Mission Bio Launches Single-Cell MRD Assay for Blood Cancer Patients
Mission Bio’s Tapestri Single-cell MRD AML Multiomics Assay is designed to bring resolution to disease relapse in acute myeloid leukemia.
Read More
Search Results for: leukemia
New Insights to Enhance Blood Cancer Diagnosis and Treatment
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read More
New AI Cell-Analysis System Streamlines Blood Disease Diagnosis
Scientists developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples.
Read More
What MDS Misdiagnoses Trends Tells Us About Blood Cancer Diagnostics
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read More
PARIS Test Finds Unexpected Cancer Treatment Options
By testing a range of therapies in organoids grown from the patient’s own tumor sample, SEngine’s PARIS Test identified off-label therapy that proved highly successful for one ovarian cancer patient.
Read More